Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., discusses their industrial odor control products, potential to help in the cannabis industry, and advancements in the medical division.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., gives an update on various milestones, including revenue and grants to help execute on their commercial strategies.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., discusses recent revenues, adding large national accounts, and developing technologies for changing the world.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., gives an update on 2018 sales, expanding regional adoption, and establishing infrastructure to handle client growth.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., discusses 2nd Quarter report, plans to grow client base, and opportunities to bring in new revenues.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., gives a detailed update on the roll out of CupriDyne Clean, wastewater treatment services, and advanced wound care.

Read more

Featured Interview: CEO Dennis Calvert of BioLargo, Inc. (OTCQB: BLGO)

CEO Dennis Calvert of BioLargo, Inc., discusses commercialization of multiple bio-technology products, including industrial odor control and waste water treatment.

Read more

Interview: CEO Guy Cook of Lattice Biologics Ltd. (OTCQB: LBLTF)

CEO Guy Cook of Lattice Biologics Ltd., discusses relocation and development of biologic products for domestic & international markets.

Read more

BioLargo Secures Financing for its Advanced Wound Care Products Targeting FDA Application, Approval and Commercialization through its Subsidiary Clyra Medical Technologies

SANTA ANA, CA–(UPTICK Newswire – January 6, 2016) – BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded

Read more